Sign in
  1. Home
  2. Companies
  3. Rite Aid Corporation
  4. Financial Ratios
Rite Aid Corporation logo
Rite Aid Corporation RAD
report update icon

Quarterly report 2024-Q2
added 05-16-2026

Rite Aid Corporation Financial Ratios 2023-2008 | RAD

Brief overview of Rite Aid Corporation's multiples and efficiency

This overview follows the five latest available observations from 2014 through 2019.

The valuation comparison uses P/E 13.98x (median 1,403.8x), EV/EBITDA 29.21x (median 28.7x), P/S 0x (median 0.02x). On average, multiples differ from their five-year medians by only +1.8%. Valuation is near its familiar historical range.

Earnings yield calculated as 1/P/E is about 7.2%, showing current profit per unit of share price.

Capital efficiency is characterized by ROE 121%, ROA -9.6%, ROCE 2.1%. Returns below zero mean resources are not producing positive profit. Recovery in operating results is the main reference point.

The cash cycle accelerated by 113.2 days to 26.4 days. Less capital is tied up in operations.

Conclusion

Rite Aid Corporation's profile looks neutral, with price and fundamental efficiency broadly aligned.

Annual Financial Ratios Rite Aid Corporation

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

P/E

 -0.2 -0.2 -5.4 -2.3 14.0 -172.2 25.4 8189.6 2593.2 1403.8 1638.7 469.6 -523.1 - - -

P/S

 0.0 0.0 0.0 0.0 0.1 0.1 0.4 5.9 5.8 5.8 4.6 1.1 1.1 - - -

EPS

 -13.2 -9.7 -1.7 -8.5 1.0 14.6 1.6 0.2 2.2 0.1 0.1 0.1 -0.1 -0.1 -3.5 -

EV (Enterprise Value)

 8.08 B 8.49 B 9.05 B 9.6 B 6.98 B 7.72 B 12.8 B 133 B 163 B 156 B 127 B 38.8 B 36.9 B 9.62 B -152 M -156 M

EBITDA per Share

 5.06 5.47 6.1 6.17 6.77 7.36 7.8 0.35 0.29 0.44 0.47 0.5 0.57 0.61 - -

EV/EBITDA

 29.2 28.7 27.7 29.2 19.5 20.0 31.4 369.7 588.0 386.6 305.8 88.2 72.9 18.0 -0.3 -

PEG

 0.02 0.03 -0.01 -0.01 0.03 -0.41 0.06 -1075.73 -198.52 5.82 -2.4 2.47 -3.44 - - -

P/B

 -0.2 1.0 0.8 1.5 0.6 0.5 3.4 211.4 2706.2 -69.6 -47.7 -11.2 -12.3 - - -

P/CF

 - - - 2.9 -1.4 33.6 -72.3 303.8 77.6 484.3 85.2 1860.6 68.7 - - -

ROE %

 121.03 -450.99 -14.65 -67.04 4.34 -0.28 13.20 2.58 104.36 -4.96 -2.91 -2.39 2.35 4.72 243.02 -

ROA %

 -9.55 -6.12 -0.97 -4.78 0.68 -0.05 0.70 0.13 0.68 1.51 1.01 0.84 -0.69 -0.98 - -

ROCE %

 - - - 2.09 -7.77 2.41 2.82 4.07 13.81 14.85 11.24 2.67 -0.39 - - -

Current Ratio

 0.9 1.0 1.1 1.1 1.2 1.2 1.1 1.1 1.0 0.8 0.7 0.7 0.8 0.8 - -

DSO

 18.9 20.8 20.9 25.6 120.3 120.0 115.0 22.7 13.3 13.4 14.0 13.8 13.9 - - -

DIO

 36.5 35.9 35.7 40.2 159.0 155.7 154.4 190.5 245.0 235.3 63.7 59.3 62.2 - - -

DPO

 29.0 28.2 27.6 32.9 139.6 139.6 138.3 110.4 101.1 102.4 28.0 26.9 25.8 - - -

Operating Cycle

 55.4 56.7 56.6 65.8 279.3 275.6 269.3 213.2 258.3 248.7 77.7 73.1 76.1 - - -

Cash Conversion Cycle

 26.4 28.5 29.0 32.9 139.6 136.0 131.1 102.8 157.2 146.3 49.7 46.2 50.4 - - -

All numbers in USD currency

Quarterly Financial Ratios Rite Aid Corporation

2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1 2010-Q3 2010-Q2

EPS

 -18.26 -5.55 -1.23 -6.07 -2.03 -1.23 -0.67 -1.86 -0.24 -0.67 0.08 -0.25 -1.19 0.08 0.97 -1.49 -1.88 0.97 0.97 -0.34 0.2 -0.09 0.08 0.16 -0.07 1.55 0.01 0.01 -0.02 0.01 0.06 0.02 0.02 0.06 0.11 0.13 0.04 0.11 0.11 0.13 0.04 0.05 0.05 0.03 0.1 0.07 0.07 -0.05 -0.03 -0.06 -0.06 -0.11 -0.07 -0.09 -0.23

EBITDA per Share

 1.25 1.19 1.27 1.26 1.29 1.27 1.35 1.37 1.41 1.35 1.55 1.63 1.48 1.55 1.54 1.57 1.58 1.54 0.08 0.08 0.09 1.64 0.09 126 0.14 0.09 0.14 0.14 0.13 0.1 0.13 0.12 0.11 0.13 0.32 0.21 0.11 0.11 0.32 0.21 - 0.03 0.32 0.22 0.11 0.03 0.35 0.23 0.12 0.04 0.38 0.25 0.13 0.43 0.28

ROE %

 202.09 1464.73 1447.30 1423.03 1304.70 -13.02 -37.29 -28.94 -11.28 -19.47 -11.12 -6.76 -12.83 -12.10 -7.74 -13.12 -29.54 -8.08 -13.46 -3.33 44.61 19.34 29.47 21.97 1.10 13.76 6.27 15.83 18.43 31.54 41.11 23.37 11.67 -2.69 -20.43 -20.08 -19.62 -19.56 -16.92 -14.63 -9.80 -11.64 -10.83 -10.02 -7.14 -2.26 2.30 6.86 9.31 11.01 12.79 20.81 2.78 3.94 10.19

ROA %

 -22.95 -10.07 -6.88 -6.45 -3.56 -2.41 -1.97 -1.54 -0.61 -1.14 -0.71 -0.27 -0.87 -1.15 -0.70 -1.25 -4.91 -1.39 -1.94 -1.17 4.72 1.49 2.26 1.67 0.31 0.93 0.34 0.72 0.78 0.99 1.37 2.33 3.98 4.40 5.35 5.40 5.40 5.40 4.95 4.44 3.06 3.75 3.61 3.47 2.46 0.77 -0.78 -2.33 -3.02 -3.46 -3.78 -5.62 -0.84 -1.01 -2.52

Current Ratio

 0.8 0.9 0.9 1.0 1.0 0.9 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.2 1.2 1.3 1.2 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.0 1.0 1.0 1.0 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.8 0.7 0.7 0.7 0.7 0.8 0.8 0.8 0.8 0.8 0.8

DSO

 23.1 23.1 22.8 23.3 22.2 24.9 25.7 24.4 25.6 26.5 27.5 26.8 25.5 25.8 30.4 31.9 29.7 28.5 31.5 33.2 30.7 29.4 30.6 30.7 30.3 29.9 30.2 29.4 26.2 26.3 27.6 16.1 14.1 20.6 10.9 11.1 13.1 13.3 12.7 13.0 12.7 12.2 12.7 13.1 13.0 13.4 13.5 13.5 13.3 14.0 4.6 13.9 13.8 - -

DIO

 39.5 40.1 37.5 38.5 37.5 36.8 35.8 35.1 35.6 36.5 36.3 36.2 36.5 36.5 41.9 41.5 41.2 41.1 40.0 39.2 40.0 40.1 51.8 43.9 35.2 52.6 42.5 40.7 40.4 60.0 42.8 45.5 41.3 61.2 43.9 46.5 56.5 56.6 56.0 58.4 - - - - - - - - - - - - - - -

DPO

 29.4 30.2 27.7 28.6 27.6 28.1 28.6 28.7 28.9 28.2 27.2 27.5 27.8 28.0 33.1 33.8 33.2 34.6 36.8 37.5 37.6 37.4 38.1 25.8 26.0 39.2 25.7 25.1 25.1 35.6 24.2 21.9 20.5 29.9 17.9 20.4 24.5 23.1 24.6 26.2 - - - - - - - - - - - - - - -

Operating Cycle

 - - - 59.8 - 60.3 20.3 58.5 - 61.5 19.8 28.9 59.8 63.8 61.8 58.0 59.2 72.3 72.4 71.0 70.2 71.5 72.3 70.7 71.5 82.8 92.7 78.7 77.5 88.0 84.4 51.2 51.0 87.8 58.4 56.9 69.6 69.9 68.7 71.4 12.7 12.7 12.9 13.2 13.4 13.5 13.5 14.1 14.0 13.9 4.6 14.0 - - -

Cash Conversion Cycle

 - - - 29.2 - 32.5 10.9 29.7 - 32.9 10.2 14.9 32.5 36.6 34.7 30.2 30.7 39.1 39.0 36.7 34.5 34.7 34.9 34.1 33.4 44.8 56.4 43.9 41.1 52.0 49.8 27.2 27.8 53.9 37.9 38.6 47.3 46.9 44.1 45.2 12.7 12.7 12.9 13.2 13.4 13.5 13.5 14.1 14.0 13.9 4.6 14.0 - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Rite Aid Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Pharmaceutical retailers industry

Issuer Price % 24h Market Cap Country
BOQI International Medical BOQI International Medical
BIMI
 		- 6.33 % $ 5.86 M chinaChina
Аптеки 36.6 Аптеки 36.6
APTK
 		- - - russiaRussia
PetMed Express PetMed Express
PETS
 		$ 1.96 -1.76 % $ 41 M usaUSA
China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc.
CJJD
 		- -5.59 % $ 49.9 M chinaChina
Trxade Group Trxade Group
MEDS
 		- 4.55 % $ 5.8 M usaUSA
Walgreens Boots Alliance Walgreens Boots Alliance
WBA
 		- - $ 10.3 B usaUSA
LifeMD LifeMD
LFMD
 		- - $ 169 M usaUSA
Greenlane Holdings Greenlane Holdings
GNLN
 		$ 2.01 -3.37 % $ 15.1 M usaUSA
111 111
YI
 		$ 3.75 -1.45 % $ 653 M chinaChina